These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26227124)

  • 1. [Not Available].
    Rexer H
    Aktuelle Urol; 2015 Jul; 46(4):282-3. PubMed ID: 26227124
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
    Elsässer-Beile U; Leiber C; Wetterauer U; Bühler P; Wolf P; Lucht M; Mengs U
    Anticancer Res; 2005; 25(6C):4733-6. PubMed ID: 16334168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
    Goebell PJ; Otto T; Suhr J; Rübben H
    J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.
    Elsässer-Beile U; Leiber C; Wolf P; Lucht M; Mengs U; Wetterauer U
    J Urol; 2005 Jul; 174(1):76-9. PubMed ID: 15947582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study.
    Rose A; El-Leithy T; vom Dorp F; Zakaria A; Eisenhardt A; Tschirdewahn S; Rübben H
    J Urol; 2015 Oct; 194(4):939-43. PubMed ID: 25910967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO].
    Rexer H;
    Urologe A; 2016 Jul; 55(7):963-5. PubMed ID: 27272001
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary bladder carcinoma - research subject recruitment!].
    Aktuelle Urol; 2014 May; 45(3):170-2. PubMed ID: 24932550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the treatment of nonmuscle invasive bladder cancer: A phase III efficacy study for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) AB 40/11 of the AUO].
    Rexer H;
    Urologe A; 2015 Mar; 54(3):406-8. PubMed ID: 25784448
    [No Abstract]   [Full Text] [Related]  

  • 9. Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done?
    Soloway MS; Arianayagam M
    Urology; 2010 Oct; 76(4):794-6. PubMed ID: 20932403
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of preserving therapy of invasive cancer of the urinary bladder].
    Matveev BP; Sallum SD; Kamolov BSh; Figurin KM; Matveev VB; Volkova MI
    Urologiia; 2005; (6):3-6. PubMed ID: 16419470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neo-adjuvant and adjuvant chemotherapy in locally advanced bladder cancer.
    Sternberg CN
    Acta Urol Belg; 1996 May; 64(2):33-4. PubMed ID: 8701807
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.
    Eisenbraun J; Scheer R; Kröz M; Schad F; Huber R
    Phytomedicine; 2011 Jan; 18(2-3):151-7. PubMed ID: 20724129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP; Zincke H; Hahn RG; Morgan WR
    Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
    [No Abstract]   [Full Text] [Related]  

  • 14. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed?
    Sylvester RJ; Oosterlinck W
    Eur Urol; 2009 Jul; 56(1):43-5. PubMed ID: 19375216
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.
    Hinotsu S; Akaza H; Naito S; Ozono S; Sumiyoshi Y; Noguchi S; Yamaguchi A; Nagamori S; Terai A; Nasu Y; Kume H; Tomita Y; Tanaka Y; Samma S; Uemura H; Koga H; Tsushima T
    BJU Int; 2011 Jul; 108(2):187-95. PubMed ID: 21176079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Photodynamic therapy of superficial cancer of the urinary bladder to prevent relapse].
    Rusakov IG; Sokolov VV; Bystrov AA
    Vopr Onkol; 2006; 52(6):675-9. PubMed ID: 17338248
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of organ-preserving therapy for invasive bladder cancer].
    Matveev BP; Figurin KM; Toktomushev AT
    Urologiia; 2002; (3):3-5. PubMed ID: 12180056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postoperative Viscum album therapy after surgery of breast neoplasms].
    Leroi R
    Helv Chir Acta; 1977 Jun; 44(3):403-14. PubMed ID: 617173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mistletoe therapy in cancer treatment: pros and cons].
    Wiebelitz KR; Beer AM; Heinrich B
    MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.